Capital Investment Advisors LLC and
Diverse Advisory Services LLC have sold shares of
Thermo Fisher Scientific Inc., while companies like
Howard Capital Management Group LLC and
QRG Capital Management Inc. have acquired TMO shares. These mixed actions reflect the stock's recent performance based on its strong fundamentals.
Thermo Fisher announced its results for Q2 2024, exceeding market returns and analyst expectations, which may indicate the company's noteworthy growth. Meanwhile, the company's recent 14% CAGR over five years outpaced its earnings growth over the same period. Are analysts' positive views about the company's financial prospects, despite the stock’s weak performance, a sign the market could be wrong?
Thermo Fisher's industrial and scientific instrument sectors are considered the best to buy by several hedge funds. The
UK's competition regulator cleared the company's $3.1 billion deal with
Olink. Despite some fluctuations in the stock value, Thermo Fisher continues to outperform the market. The company's future outlook remains positive, driven by innovative product introductions and solid financial performance.
Thermo Fisher Scientific TMO News Analytics from Wed, 27 Dec 2023 08:00:00 GMT to Sun, 11 Aug 2024 16:38:46 GMT -
Rating 7
- Innovation 5
- Information 8
- Rumor -3
